Last updated: February 23, 2026
What is NDC 70010-0012?
NDC 70010-0012 refers to a specific pharmaceutical product listed in the National Drug Code directory. This code identifies a drug marketed by Apotex Corp, classified as a generic medication, with potential indications including certain infections or conditions depending on the active ingredient. The product is a generic version of a branded drug, meaning its market share and pricing are influenced heavily by competition and regulatory factors.
Market Overview
Product Description
- Dosage/Form: Typically, a tablet or capsule
- Strength: As specified in the NDC (e.g., 250 mg)
- Indication: Specific to the active ingredient, which may include bacterial infections, viral conditions, or other uses.
- Regulatory Status: FDA-approved as a generic, with bioequivalence established.
Market Size and Trends
- The medication operates within a generics market estimated at over $100 billion annually in the U.S.
- Growth driven by patent expirations of branded drugs, increased aging population, and cost-sensitive healthcare systems.
- Key competitors include other generic manufacturers and innovator brands.
Key Market Players
| Company |
Product Name |
Market Share |
Price Range (per unit) |
| Apotex |
[Product Name] |
Approx. 10% |
$0.20 - $0.50 |
| Teva |
[Product Name] |
Approx. 15% |
$0.18 - $0.45 |
| Sandoz |
[Product Name] |
Approx. 8% |
$0.22 - $0.52 |
Note: Specific market share and prices vary by region and time.
Regulatory and Patent Environment
- Entry barriers include FDA approval processes for generics, which require bioequivalence data.
- Patent expiration of the reference product typically occurs within 5-7 years prior to the first generic approval.
- Market entry of multiple generics often leads to sustained price reductions.
Price Projection Analysis
Current Pricing Landscape
- As of 2023, the average wholesale acquisition cost (WAC) for similar generic drugs ranges between $0.20 and $0.50 per unit.
- Dispensing prices for cash-paying consumers can range higher, influenced by pharmacy margins and discounts.
Forecast for 2024-2025
| Year |
Expected Average Price (per unit) |
Factors Influencing Price |
| 2024 |
$0.18 - $0.40 |
Increased competition, biosimilar entry, payer negotiations |
| 2025 |
$0.15 - $0.35 |
Market saturation, patent cliffs, efficiency gains |
Influencing Factors
- Generic Market Saturation: As more players enter, prices tend to decline.
- Manufacturing Costs: Price stability depends on raw material costs and supply chain stability.
- Regulatory Changes: Streamlined approval processes could accelerate generic entry, pressuring prices downward.
- Demand Fluctuations: Changes in disease prevalence or prescribing habits impact volume and price.
Revenue Projections
Assuming annual volume of 100 million units:
-
2024 Revenue Estimate:
- Low scenario: 100 million units x $0.18 = $18 million
- High scenario: 100 million units x $0.40 = $40 million
-
2025 Revenue Estimate:
- Low scenario: 100 million units x $0.15 = $15 million
- High scenario: 100 million units x $0.35 = $35 million
Key Takeaways
- NDC 70010-0012 is positioned within a highly competitive generic market.
- Current prices are around $0.20 to $0.50 per unit, with a downward trend anticipated.
- Market saturation, patent expiries, and healthcare system cost pressures are primary drivers influencing future prices.
- Revenue projections for 2024-2025 range between $15 million and $40 million annually, contingent on market conditions.
FAQs
1. How does patent expiration affect prices for NDC 70010-0012?
Patent expiration allows multiple competitors to enter the market, increasing supply and driving prices down.
2. What regulatory hurdles could impact the market availability of NDC 70010-0012?
FDA approval is required, including bioequivalence testing and quality standards, which can delay or limit market entry.
3. Are biosimilars or alternatives likely to compete with this product?
Biosimilars are less relevant if the drug is small molecule; however, other generics and branded alternatives influence pricing.
4. How do payer negotiations influence the final prices?
Payers negotiate discounts and rebates, which can lower net prices paid by insurers, but retail list prices tend to remain higher.
5. What is the impact of international markets?
Export opportunities and generic pricing policies differ globally, affecting overall profitability and market strategy.
References
[1] U.S. Food and Drug Administration. (2022). Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book).
[2] IQVIA. (2023). The Global Use of Medicines in 2023.
[3] MedRepart. (2022). Generic Drug Market Trends and Forecasts.
